APA (7th ed.) Citation

D, D., K, B., MA, L., CJ, P., GJ, X., Q, S., . . . VL, W. (2024). Wnt/β-catenin signaling is a therapeutic target in anaplastic thyroid carcinoma. Endocrine, 86(1), 114. https://doi.org/10.1007/s12020-024-03887-0

Chicago Style (17th ed.) Citation

D, Diaz, et al. "Wnt/β-catenin Signaling Is a Therapeutic Target in Anaplastic Thyroid Carcinoma." Endocrine 86, no. 1 (2024): 114. https://doi.org/10.1007/s12020-024-03887-0.

MLA (9th ed.) Citation

D, Diaz, et al. "Wnt/β-catenin Signaling Is a Therapeutic Target in Anaplastic Thyroid Carcinoma." Endocrine, vol. 86, no. 1, 2024, p. 114, https://doi.org/10.1007/s12020-024-03887-0.